M&G Investment Management LTD Bausch Health Companies Inc. Transaction History

M&G Investment Management LTD

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 25, 2022	SELL	$7.06 - $23.63 $1,094 - $3,662	-155 Reduced 0.1%	150,457 $1.29 Million
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $78,645 - $101,183	3,641 Added 2.48%	150,612 $3.49 Million
Q4 2021 Jan 18, 2022	SELL	$23.0 - $29.01 $3,749 - $4,728	-163 Reduced 0.11%	146,971 $4.07 Million
Q3 2021 Nov 09, 2021	SELL	$25.04 - $30.06 $713,264 - $856,259	-28,485 Reduced 16.22%	147,134 $4.1 Million
Q2 2021 Aug 16, 2021	SELL	$27.43 - $32.7 $27,430 - $32,700	-1,000 Reduced 0.57%	175,619 $5.1 Million
Q4 2020 Feb 02, 2021	BUY	$15.31 - $21.12 $303,735 - $418,999	19,839 Added 12.65%	176,619 $3.61 Million
Q3 2020 Oct 26, 2020	SELL	$14.88 - $20.13 $1,428 - $1,932	-96 Reduced 0.06%	156,780 $2.47 Million
Q2 2020 Jul 22, 2020	SELL	$13.31 - $20.51 $596,780 - $919,606	-44,837 Reduced 22.23%	156,876 $2.89 Million
Q1 2020 Apr 09, 2020	BUY	$12.98 - $30.25 $40,549 - $94,501	3,124 Added 1.57%	201,713 $3.16 Million
Q4 2019 Jan 28, 2020	BUY	$18.89 - $31.89 $3.75 Million - $6.33 Million	198,589 New	198,589 $5.97 Million

258

255M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.79B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on M&G Investment Management LTD with notifications on news.